PainReform Ltd.
PRFX
$1.12
$0.076.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.66% | -8.99% | -16.37% | -24.38% | -28.63% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -76.83% | -19.17% | 53.10% | 87.10% | 77.90% |
| Operating Income | 76.83% | 19.17% | -53.10% | -87.10% | -77.90% |
| Income Before Tax | 76.91% | 18.37% | -56.17% | -144.18% | -81.09% |
| Income Tax Expenses | 0.00% | 0.00% | 0.00% | 33.33% | -11.11% |
| Earnings from Continuing Operations | 76.88% | 18.35% | -56.12% | -144.05% | -81.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 76.88% | 18.35% | -56.12% | -144.05% | -81.00% |
| EBIT | 76.83% | 19.17% | -53.10% | -87.10% | -77.90% |
| EBITDA | 77.87% | 19.87% | -53.17% | -87.21% | -78.07% |
| EPS Basic | 98.59% | 86.93% | 48.45% | 3.06% | 24.89% |
| Normalized Basic EPS | 98.59% | 86.93% | 48.42% | 3.02% | 24.88% |
| EPS Diluted | 98.59% | 86.93% | 48.46% | 3.08% | 24.91% |
| Normalized Diluted EPS | 98.59% | 86.93% | 48.42% | 3.02% | 24.88% |
| Average Basic Shares Outstanding | 1,248.42% | 1,996.46% | 1,436.15% | 882.70% | 194.59% |
| Average Diluted Shares Outstanding | 1,248.42% | 1,996.46% | 1,436.15% | 882.70% | 194.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |